Form 4: Lemaitre Vascular CFO Reports Acquisition of Dividend Equivalent Rights
Insider Transaction Report
Lemaitre Vascular's Chief Financial Officer, Dorian Paul LeBlanc, reported the acquisition of 3.0197 dividend equivalent rights, linked to a restricted stock unit award, on May 29, 2025.
Summary
- Dorian Paul LeBlanc, Chief Financial Officer of Lemaitre Vascular Inc. (LMAT), reported a transaction involving the acquisition of securities.
- The transaction, dated May 29, 2025, involved the acquisition of 3.0197 Dividend Equivalent Rights.
- These rights accrued on a restricted stock unit (RSU) award that was granted on March 10, 2025.
- Each dividend equivalent right is the economic equivalent of one share of Lemaitre Vascular's common stock.
- The acquired dividend equivalent rights vest proportionately with the underlying restricted stock unit award.
- Following this reported transaction, Mr. LeBlanc beneficially owns a total of 5.9297 Dividend Equivalent Rights.
Sentiment
Score: 5
Explanation: The document reports a routine insider transaction related to executive compensation, which is neutral in sentiment. It does not indicate any significant positive or negative operational or financial developments for the company.
Positives
- The accrual of dividend equivalent rights indicates ongoing executive compensation through equity awards, which typically aims to align management's interests with those of shareholders.
Future Outlook
NA
Industry Context
This Form 4 filing details a routine insider transaction related to executive compensation, which is specific to Lemaitre Vascular Inc. and does not provide broader insights into industry trends or competitive dynamics.
Related Party Transactions
- The transaction involves dividend equivalent rights accruing on a restricted stock unit award granted to Dorian Paul LeBlanc, the Chief Financial Officer, as part of his executive compensation package.
Stakeholder Impact
- Shareholders: The transaction reflects the ongoing equity-based compensation structure for executives, which aims to align management's long-term interests with shareholder value creation.
Next Steps
- The dividend equivalent rights will vest proportionately with the underlying restricted stock unit award.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of restricted stock unit (RSU) award grant on which dividend equivalent rights accrued. |
| 05/29/2025 | Date of transaction for the acquisition of dividend equivalent rights. |
| 06/02/2025 | Date the Form 4 filing was signed. |
Keywords
Lemaitre Vascular, LMAT, Form 4, insider transaction, beneficial ownership, dividend equivalent rights, restricted stock units, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.